Cadre Holdings, Inc.

CDRE ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Revenue $610.3M $567.6M $482.5M $457.8M $427.3M $404.6M
Cost of Revenue $350.7M $334.1M $281.8M $282.2M $256.6M $251.7M
Gross Profit $259.6M $233.5M $200.7M $175.7M $170.7M $152.9M
Gross Margin 42.5% 41.1% 41.6% 38.4% 39.9% 37.8%
Operating Expenses
Research & Development $11.4M $8.4M $7.0M $7.1M $6.5M $5.6M
SG&A Expense $183.1M $158.3M $140.5M $153.1M $115.0M $106.6M
Operating Income $67.4M $66.8M $56.5M $16.7M $51.7M $49.8M
Operating Margin 11.0% 11.8% 11.7% 3.7% 12.1% 12.3%
Interest Expense $4.5M $6.2M $16.4M $24.4M
Pretax Income $62.3M $54.2M $52.9M $9.4M $19.2M $27.9M
Income Tax Expense $18.2M $18.1M $14.3M $3.6M $6.5M $-10.6M
Net Income $44.1M $36.1M $38.6M $5.8M $12.7M $38.5M
Net Margin 7.2% 6.4% 8.0% 1.3% 3.0% 9.5%
EPS (Basic) $1.08 $0.90 $1.03 $0.16 $0.44 $1.40
EPS (Diluted) $1.02 $0.90 $1.02 $0.16 $0.44 $1.40
Shares Outstanding (Basic) 40.9M 39.9M 37.5M 36.1M 28.6M 27.5M
Shares Outstanding (Diluted) 43.4M 40.3M 37.9M 36.1M 28.6M 27.5M
Dividends Per Share $0.10 $0.09 $0.08 $0.08